NCT06923124

A Study to Describe a Group of Spanish Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on Quality of Life

A Retrospective, Non-interventional, Single-center Study to Describe a Spanish Cohort of Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on HRQoL (Health-Related Quality of Life)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 44 (actual)
• Sponsor: Novartis Pharmaceuticals · Industry
• Sex: All
• Age: 28 Years
• Healthy volunteers: Not accepted

Summary

A retrospective, non-interventional, single-center study conducted in Spain, based on the collection of data from the medical histories of patients with Familial Mediterranean fever (FMF) diagnosed during childhood from January 2005 to December 2021. Data from the patients' medical records was collected retrospectively, from the time of diagnosis to the current moment of the patient's enrollment in the study. Patients had a minimum follow-up of 3 months after diagnosis.

Conditions

• Familial Mediterranean Fever

Timeline

• Start date: 2023-03-30
• Primary completion: 2024-05-28
• Completion: 2024-05-28
• First posted: 2025-04-11
• Last updated: 2025-04-11

Locations

1 site across 1 country: United States